Summit Therapeutics EBIT 2015-2024 | SMMT

Summit Therapeutics EBIT for the quarter ending September 30, 2024 was $-0.058B, a 184.88% increase year-over-year.

  • Summit Therapeutics 2023 EBIT was -0.61B, a 745.69% increase from 2022.
  • Summit Therapeutics 2022 EBIT was -0.072B, a 16.36% decline from 2021.
  • Summit Therapeutics 2021 EBIT was -0.086B, a 62.03% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Summit Therapeutics EBIT 2015-2024 | SMMT

  • Summit Therapeutics 2023 EBIT was -0.61B, a 745.69% increase from 2022.
  • Summit Therapeutics 2022 EBIT was -0.072B, a 16.36% decline from 2021.
  • Summit Therapeutics 2021 EBIT was -0.086B, a 62.03% increase from 2020.

EBIT can be defined as earnings before interest and taxes.